Advances in medicine and biology. Volume 45 / edited by Leon V. Berhardt.
Material type: TextPublication details: Hauppauge, N.Y. : Nova Science ; Lancaster : Gazelle [distributor], 2012.Description: 1 online resource (xii, 231 pages)Content type:- text
- computer
- online resource
- 9781621009641
- 1621009645
- 610.28 23
- R850
Item type | Home library | Collection | Call number | Materials specified | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Electronic-Books | OPJGU Sonepat- Campus | E-Books EBSCO | Available |
Includes bibliographical references and index.
Print version record.
ADVANCES IN MEDICINE AND BIOLOGY VOLUME 45 ; ADVANCES IN MEDICINE AND BIOLOGY VOLUME 45 ; CONTENTS ; PREFACE; CORTICOTROPIN AND REPRODUCTION ; ABSTRACT ; 1. INTRODUCTION ; 2. PITUITARY ADRENAL AXIS AND GONADOTROPINS ; 3. THE "STRESS" PARADIGM ; 4. ANOREXIA NERVOSA ; 5. ADRENAL HYPERPLASIA; 6. ACTH AND PREGNANCY ; 7. ADRENAL AND OXIDATIVE STRESS; 8. ACTH ADMINISTRATION IN CHRONIC DISEASE ; CONCLUSION ; REFERENCES ; ACTIONS OF MORPHINE AND ITS RELATED DRUGS ON PRIMARY-AFFERENT NEURONS: THEIR CLINICAL SIGNIFICANCES; ABSTRACT ; INTRODUCTION ; OPIOID RECEPTORS IN PRIMARY-AFFERENT NEURONS.
ACTIONS ON THE CENTRAL TERMINALS OF PRIMARY-AFFERENT NEURONSInhibition by Opioids of L-Glutamate Release from Nerve Terminals ; Clinical Significance ; ACTIONS ON THE PERIPHERAL TERMINALS OF PRIMARY-AFFERENT NEURONS ; Inhibition by Opioids of Action Potential Production; Clinical Significance ; ACTIONS ON PERIPHERAL NERVE FIBERS ; Inhibition of Compound Action Potential by Opioids ; Structure-Activity Relation for Compound Action Potential Inhibition by Opioids ; Inhibition by Opioids of Action Potentials Recorded from Dorsal Root Ganglion Neurons; Clinical Significance ; CONCLUSIONS.
5.4. Children 5.5. Geriatric Patients; 6. SAFETY AND ADVERSE EVENTS ; 6.1. Safety ; 6.1.1. Respiratory Depression ; 6.1.2. Head Injury and Increased Intracranial Pressure ; 6.1.3. Hypotensive Effects ; 6.1.4. Acute Abdominal Conditions; 6.1.5. Myoclonic Spasms ; 6.1.6. Hypersensitivity Reactions and Sulfite Sensitivity ; 6.1.7. Central Nervous System Effects ; 6.1.8. Pancreatic and Biliary Disease ; 6.1.9. Cardiac Arrhythmia ; 6.1.10. Fetus ; 6.1.11. Overdose in Renal or Hepatic Impairment; 6.2. Adverse Effects ; 6.2.1. Respiratory Depression ; 6.2.2. Tolerance and Myoclonus; 6.2.3. Pruritus.
6.2.4. Urinary Retention 6.2.5. Constipation ; Constipation is a Major Adverse Effect of Morphine Administration for Pain Relief ; 6.2.6. Other ; 7. DRUG-DRUG INTERACTIONS (DDI) ; 8. DEPENDENCE AND ABUSE ; 9. ABUSE-RESISTANT/DETERRENT FORMULATIONS ; 9.1. Combinations ; 10. MORPHINE-6-GLUCORONIDE ; CONCLUSION ; REFERENCES ; LABORING THROUGH PAIN: BODY, MIND, AND EMOTION WORK AMONG MIDWIFERY CLIENTS ; ABSTRACT ; LABORING THROUGH PAIN: BODY, MIND, AND EMOTION WORK AMONG MIDWIFERY CLIENTS ; Body Work ; Mind Work ; Emotion Work ; RESEARCH METHOD ; RESULTS; Body Work ; Mind Work ; Emotion Work.
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide
There are no comments on this title.